具身智能备受青睐，首形科技完成过亿元A+轮融资｜投融资周报

Investment Trends - The investment in the robotics sector is heating up, with embodied intelligence gaining significant attention, and the autonomous driving sector showing notable highlights [1] - In the past week, Didi Autonomous Driving announced a D-round financing of 2 billion yuan, with participation from various funds and companies [1][38] - The medical health sector, particularly biomedicine, has shown stable performance in financing, with Chengdu Nureter Medical Technology completing nearly 800 million yuan in D-round financing [1][18] Financing Overview - From September 29 to October 12, there were 34 financing events in the domestic primary market, with a total disclosed amount of approximately 9.645 billion yuan [1][2] - The majority of financing was in RMB, with 30 cases totaling about 9.105 billion yuan, and one case in USD amounting to 75 million [2] Sector-Specific Financing - The technology and manufacturing sectors saw the highest number of financing events, with the robotics sector completing 4 financings totaling approximately 340 million yuan [3][4] - The artificial intelligence sector had 14 financing events, with a total disclosed amount of 510 million yuan [4] Regional Distribution - The financing activities were primarily concentrated in Zhejiang, Jiangsu, and Guangdong provinces, with 7, 6, and 4 cases respectively [5][6] Active Investment Institutions - Yinxinggu Capital was notably active, completing 2 financings primarily in the technology and manufacturing sectors [7][8] Notable Company Financing - Natural Hall Group completed 300 million yuan in strategic financing, with participation from global beauty giant L'Oréal [1][8] - Zhejiang Weiming Shiguang Biotechnology secured several million yuan in B+ round financing for AI technology platform development [1][9] - Tianjing Biotechnology completed nearly 600 million yuan in C2 round financing led by a fund under CICC [1][10] - Rui Zheng Gene completed 75 million USD in A round financing, focusing on gene editing drug development [1][11] - Shanghai Yushen Robot Technology raised millions in angel round financing to advance core technology and market expansion [1][13][14]